Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Latest aspects in psoriasis pathogenesis].

J C Prinz1

  • 1Klinik und Poliklinik für Dermatologie und Allergologie der LMU München, Munich. joerg.prinz@lrz.uni-muenchen.de

Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete
|March 14, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of psoriasis with biologic and non-biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN-FRT expert consensus.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Influence of Covid-19 vaccination on immune-mediated skin diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2022
Same author

Lesional activation of T<sub>c</sub> 17 cells in Behçet disease and psoriasis supports HLA class I-mediated autoimmune responses.

The British journal of dermatology·2021
Same author

[Psoriasis in dupilumab-treated atopic dermatitis].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2020
Same author

[In honor of Prof. Dr. med. Dr. h.c. mult. Gerd Plewig on the occasion of his 80th birthday : Gerd Plewid-a lifetime for dermatology].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2019
Same author

The therapeutic potential of TNF-α antagonists in toxic epidermal necrosis: insights from two cases and adverse event reports.

Journal of the European Academy of Dermatology and Venereology : JEADV·2018
Same journal

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral infections of the skin].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Viral exanthems in children].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Erratum to: Digital health applications and data protection].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Virus-induced exanthems in returning travellers].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
Same journal

[Venous ulcus cruris-Surgical treatment].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete·2022
See all related articles

Psoriasis is a T cell-mediated skin inflammation influenced by genetics and microbes. Targeting these T cells and their cytokines offers new, effective psoriasis treatment strategies.

Area of Science:

  • Immunology
  • Dermatology
  • Genetics

Context:

  • Psoriasis pathogenesis understanding has evolved significantly.
  • It is now recognized as a T cell-mediated skin inflammation.
  • Genetic and microbial factors interplay in its induction.

Purpose:

  • To elucidate the updated understanding of psoriasis pathogenesis.
  • To highlight the role of T cells and cytokines in disease development.
  • To discuss the implications for future therapeutic strategies.

Summary:

  • Psoriasis is characterized by T cell-mediated inflammation.
  • Antigen-specific T cell responses, influenced by genetics and environment, are central.
  • The specific differentiation of pathogenic T cells dictates the inflammatory phenotype.

Related Experiment Videos

Impact:

  • Identifies T cells and cytokines as key targets for novel treatments.
  • Suggests a paradigm shift in psoriasis therapy is imminent.
  • Promises more causal and effective therapeutic approaches for psoriasis patients.